Hepatic Impairment Completed Phase 1 Trials for Teduglutide (DB08900)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

DBCOND0031585 (Hepatic Impairment)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00819468Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy ParticipantsOther